Thanks for emailing that article!
The 6th Annual Glaucoma 360 New Horizons Forum took place at the Palace Hotel in San Francisco on February 3, 2017.
New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. Launched in 2012 by the Glaucoma Research Foundation, this catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice.
Joel S. Schuman, MD, FACS gave the keynote lecture at the 2017 New Horizons Forum.
Some of the more than 300 attendees gain insights during a full day of presentations at New Horizons Forum.
Opening the day of sessions, Glaucoma 360 Co-founder and Co-chair Adrienne Graves, PhD announced that "Glaucoma is Hot!"
The panel on New Horizons in Drug Delivery was moderated by L. Jay Katz, MD and Cheryl Rowe-Rendleman, PhD.
Jeffrey L. Goldberg, MD, PhD spoke about biomarkers and drug discovery at New Horizons Forum.
Lama Al-Aswad, MD, MPH and Louis R. Pasquale, MD moderated the panel on New Horizons in Telemedicine.
Steven Vold, MD interviews Dr. Lama Al-Aswad for Glaucoma Today at Glaucoma 360 New Horizons Forum.
Jamie Metzinger with Ocular Therapeutix networking in the Sunset Court exhibit hall at New Horizons Forum.
Drs. Richard Lewis, Adrienne Graves, and Thomas Samuelson enjoy the reception.
Ruth D. Williams, MD gave the Forum Summation.
Guests enjoy the reception in the Sunset Court.
Drs. Robert Fechtner, Adrienne Graves, Andrew Iwach, and Joel S. Schuman.
The morning and afternoon "catalysts" - Drs. Rob Fechtner and Steven Vold.
Save the date for the 7th Annual Glaucoma 360 New Horizons Forum -- February 9, 2018.
Photography by Trish Tunney.
Last reviewed on October 29, 2017